HARBOURVEST PARTNERS LLC - OYSTER PT PHARMA INC ownership

OYSTER PT PHARMA INC's ticker is OYST and the CUSIP is 69242L106. A total of 61 filers reported holding OYSTER PT PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
HARBOURVEST PARTNERS LLC ownership history of OYSTER PT PHARMA INC
ValueSharesWeighting
Q3 2022$71,000
+31.5%
12,5600.0%0.02%
+27.8%
Q2 2022$54,000
-63.0%
12,5600.0%0.02%
-40.0%
Q1 2022$146,000
-36.2%
12,5600.0%0.03%
+3.4%
Q4 2021$229,000
+53.7%
12,5600.0%0.03%
+107.1%
Q3 2021$149,000
-44.2%
12,560
-19.2%
0.01%
-46.2%
Q2 2021$267,000
-57.3%
15,545
-54.5%
0.03%
-69.0%
Q1 2021$625,00034,1850.08%
Other shareholders
OYSTER PT PHARMA INC shareholders Q2 2022
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 2,768,586$15,559,0008.54%
NEA Management Company, LLC 5,925,287$33,300,0001.66%
KPCB XIV Associates, LLC 367,987$2,068,0001.61%
Paradigm Biocapital Advisors LP 1,648,316$9,264,0001.24%
Telemark Asset Management, LLC 777,026$4,367,0000.69%
COWEN AND COMPANY, LLC 509,794$2,865,0000.27%
RTW INVESTMENTS, LP 2,044,312$11,489,0000.26%
Kohlberg Kravis Roberts & Co. L.P. 1,039,622$5,843,0000.12%
Wildcat Capital Management, LLC 36,847$207,0000.08%
ACT CAPITAL MANAGEMENT, LLC 8,500$48,0000.07%
View complete list of OYSTER PT PHARMA INC shareholders